NetworkNewsBreaks – Singular Research Initiates
Post# of 2022
Singular Research, a supplier of independent, single-source research on smallcap and microcap companies, recently initiated coverage with a ‘BUY’ rating and a price target of $2.00 on shares of EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry. Among other highlights, the report notes EVIO’s future growth prospects that are driven by investment capital, the rollout of new laboratories nationwide and the addition of new executive management members.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer